title: Effect of exercise intensity on skeletal muscle AMPK signaling in humans.
abstract: The effect of exercise intensity on skeletal muscle AMP-activated protein kinase (AMPK) signaling and substrate metabolism was examined in eight men cycling for 20 min at each of three sequential intensities: low (40 +/- 2% VO(2) peak), medium (59 +/- 1% VO(2) peak), and high (79 +/- 1% VO(2) peak). Muscle free AMP/ATP ratio only increased at the two higher exercise intensities (P < 0.05). AMPK alpha 1 (1.5-fold) and AMPK alpha 2 (5-fold) activities increased from low to medium intensity, with AMPK alpha 2 activity increasing further from medium to high intensity. The upstream AMPK kinase activity was substantial at rest and only increased 50% with exercise, indicating that, initially, signaling through AMPK did not require AMPK kinase posttranslational modification. Acetyl-CoA carboxylase (ACC)-beta phosphorylation was sensitive to exercise, increasing threefold from rest to low intensity, whereas neuronal NO synthase (nNOS) micro phosphorylation was only observed at the higher exercise intensities. Glucose disappearance (tracer) did not increase from rest to low intensity, but increased sequentially from low to medium to high intensity. Calculated fat oxidation increased from rest to low intensity in parallel with ACC beta phosphorylation, then declined during high intensity. These results indicate that ACC beta phosphorylation is especially sensitive to exercise and tightly coupled to AMPK signaling and that AMPK activation does not depend on AMPK kinase activation during exercise.
authors.affiliation: St. Vincent's Institute of Medical Research, University of Melbourne, Fitzroy, Victoria, Australia.
authors.forename: Zhi-Ping
authors.initials: ZP
authors.lastname: Chen
authors.forename: Terry J
authors.initials: TJ
authors.lastname: Stephens
authors.forename: Sid
authors.initials: S
authors.lastname: Murthy
authors.forename: Benedict J
authors.initials: BJ
authors.lastname: Canny
authors.forename: Mark
authors.initials: M
authors.lastname: Hargreaves
authors.forename: Lee A
authors.initials: LA
authors.lastname: Witters
authors.forename: Bruce E
authors.initials: BE
authors.lastname: Kemp
authors.forename: Glenn K
authors.initials: GK
authors.lastname: McConell
mesh_terms: D000091162:AMP-Activated Protein Kinase Kinases; D000328:Adult; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005947:Glucose / Q000493:pharmacokinetics; D006801:Humans; D008297:Male; D018482:Muscle, Skeletal / Q000201:enzymology*; D009569:Nitric Oxide / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000378:metabolism; D052248:Nitric Oxide Synthase Type I; D010101:Oxygen Consumption / Q000502:physiology; D010766:Phosphorylation; D005082:Physical Exertion / Q000502:physiology*; D011494:Protein Kinases / Q000378:metabolism*; D012146:Rest / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology*
chemical_list: D005230:Fatty Acids, Nonesterified; D009569:Nitric Oxide; C496320:NOS1 protein, human; D019001:Nitric Oxide Synthase; D052248:Nitric Oxide Synthase Type I; D011494:Protein Kinases; D000091162:AMP-Activated Protein Kinase Kinases; D005947:Glucose